GASTROINTESTINAL HEMORRHAGE IN THE NEW-BORN.

On the treatment of new oral anticoagulant-associated gastrointestinal hemorrhage.

The recently introduced new oral anticoagulants (nOAC) carry a higher gastrointestinal bleeding risk compared to traditional antithrombotic therapy. Current diagnostic coagulation tests are not accurate enough to determine the level of coagulopathy. Besides that, the lack of a specific antidote leaves the endoscopist unsure how to achieve hemostasis during gastrointestinal hemorrhage. In this b...

Upper gastrointestinal hemorrhage: have new therapeutics made a difference?

BACKGROUND To explore the distribution of etiologies and risk factors of upper gastrointestinal hemorrhage (UGH) in the context of new pharmacologic therapies that may alter the risk of UGH. METHODS Retrospective study performed on eligible UGH inpatients at 2 academic medical centers, between July 1, 2001 and June 30, 2003. Administrative data and chart review were used to identify demograph...

Cryptosporidium spp. in new born lambs in IRAN

A Case of Neurotibromatosis in A 5-Month New Born

SUMMARY Neurofibromatosis, an autosomal dominant disorder is characterized by showan cell tumor affecting any Part of the body containing such cell, giving rise to appropriate fealture according to the organ involved but the most characteristic clinical aspect of the disease is pripheral or cranial nerve tumors usually associated with cafe au lait spots more than 6 in number and larger than 1....

Malaria in the New-Born